Meghan Brady Marmor, MD
Pulmonary Disease · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · El Camino Health · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Marmor’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A141347 · Current
Licensed to practise in California · since 2016 · expires 2027-11-30 · University of Arizona College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$72,494
Medicare paid this office $72,494 for 489 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 80 | $32,022 | $185 |
| Long return visit (40+ min) | 34 | $6,537 | $145 |
| Return visit (30+ min) | 41 | $4,597 | $102 |
| Long return visit (40+ min) | 21 | $3,009 | $125 |
| Short return visit (20+ min) | 36 | $2,690 | $69 |
See all 18 services
| Critical care, first 30-74 minutes | 80 | $32,022 | $185 |
| Long return visit (40+ min) | 34 | $6,537 | $145 |
| Return visit (30+ min) | 41 | $4,597 | $102 |
| Long return visit (40+ min) | 21 | $3,009 | $125 |
| Short return visit (20+ min) | 36 | $2,690 | $69 |
| Return visit (30+ min) | 27 | $2,289 | $82 |
| New patient visit (60+ min) | 14 | $2,267 | $162 |
| Critical care, each additional 30 minutes | 16 | $1,859 | $93 |
| Short return visit (20+ min) | 30 | $1,669 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,130 | $71 |
| Test to examine how well the lungs exchange gases | 93 | $727 | $8 |
| Test to examine how well the lungs exchange gases | 85 | $662 | $8 |
| Test to determine lung volumes using sensors | 61 | $620 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 68 | $611 | $9 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 64 | $549 | $9 |
| Test to measure expiratory airflow and volume | 67 | $515 | $7 |
| Test to determine lung volumes using sensors | 43 | $449 | $10 |
| Test to measure expiratory airflow and volume | 37 | $280 | $7 |
Who their Medicare patients are
489 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 12% · Women 62% · Also on Medicaid 23% · Health risk score 1.94. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 69% · COPD 51% · Coronary heart disease 34% · Chronic kidney disease 32% · Heart failure 30% · Diabetes 28% · Atrial fibrillation 27% · Cancer 22% · Depression 22% · Stroke 12% · Dementia 10%.
The office billed $544,308, Medicare allowed $91,972 and paid $72,494; for 1,084 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 489 | 1,084 | 74 | 1.94 | $544,308 | $72,494 |
| 2023 | 474 | 985 | 75 | 2.06 | $602,805 | $76,895 |
| 2022 | 429 | 942 | 74 | 1.91 | $472,515 | $61,274 |
| 2021 | 479 | 1,188 | 74 | 1.77 | $607,148 | $85,166 |
| 2020 | 413 | 993 | 73 | 2.24 | $435,295 | $67,678 |
| 2019 | 205 | 466 | 74 | 1.81 | $138,380 | $28,176 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Critical care, first 30-74 minutes | 91 | $33,989 | $187 |
| Long return visit (40+ min) | 38 | $5,291 | $113 |
| Long return visit (40+ min) | 37 | $5,263 | $120 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,158 | $160 |
| Return visit (30+ min) | 40 | $4,050 | $86 |
| Return visit (30+ min) | 34 | $3,134 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,058 | $109 |
| Critical care, each additional 30 minutes | 20 | $2,756 | $95 |
| New patient visit (60+ min) | 16 | $2,666 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $944 | $73 |
| Test to examine how well the lungs exchange gases | 76 | $565 | $7 |
| Test to examine how well the lungs exchange gases | 61 | $501 | $8 |
| Short return visit (20+ min) | 15 | $488 | $33 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 15 | $483 | $32 |
| Test to determine lung volumes using sensors | 46 | $441 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 52 | $431 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 46 | $412 | $9 |
| Test to determine lung volumes using sensors | 31 | $329 | $11 |
| Test to measure expiratory airflow and volume | 40 | $314 | $7 |
| Test to measure expiratory airflow and volume | 36 | $250 | $7 |
2022: 18 services
| Critical care, first 30-74 minutes | 55 | $22,434 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $5,694 | $92 |
| Long return visit (40+ min) | 31 | $4,469 | $124 |
| Long return visit (40+ min) | 28 | $4,013 | $122 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,870 | $179 |
| Return visit (30+ min) | 18 | $2,160 | $86 |
| Return visit (30+ min) | 24 | $2,127 | $85 |
| Aspiration of fluid from chest cavity using imaging guidance | 13 | $1,285 | $99 |
| Short return visit (20+ min) | 16 | $955 | $53 |
| Short return visit (20+ min) | 15 | $946 | $59 |
| Test to examine how well the lungs exchange gases | 78 | $660 | $8 |
| Test to examine how well the lungs exchange gases | 81 | $637 | $8 |
| Test to determine lung volumes using sensors | 59 | $613 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 58 | $556 | $9 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 62 | $546 | $9 |
| Test to determine lung volumes using sensors | 42 | $474 | $11 |
| Test to measure expiratory airflow and volume | 50 | $385 | $8 |
| Test to measure expiratory airflow and volume | 30 | $221 | $7 |
2021: 19 services
| Critical care, first 30-74 minutes | 80 | $34,397 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $7,131 | $94 |
| Long return visit (40+ min) | 44 | $6,871 | $118 |
| Long return visit (40+ min) | 28 | $4,467 | $121 |
| Return visit (30+ min) | 44 | $3,924 | $83 |
| New patient visit (60+ min) | 20 | $3,198 | $160 |
| Return visit (30+ min) | 30 | $2,958 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,591 | $185 |
| New patient visit (60+ min) | 15 | $2,336 | $156 |
| Short return visit (20+ min) | 32 | $2,152 | $58 |
| Short return visit (20+ min) | 18 | $1,243 | $59 |
| Test to examine how well the lungs exchange gases | 136 | $1,168 | $8 |
| Test to determine lung volumes using sensors | 103 | $1,136 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 107 | $1,029 | $9 |
| Test to measure expiratory airflow and volume | 49 | $395 | $7 |
| Test to examine how well the lungs exchange gases | 45 | $350 | $8 |
| Test to measure expiratory airflow and volume | 32 | $224 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $216 | $9 |
| Test to determine lung volumes using sensors | 17 | $180 | $11 |
2020: 18 services
| Critical care, first 30-74 minutes | 62 | $24,376 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $5,344 | $95 |
| Return visit (30+ min) | 49 | $5,196 | $71 |
| New patient visit (60+ min) | 28 | $4,201 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,783 | $122 |
| New patient visit (60+ min) | 25 | $3,716 | $149 |
| Long return visit (40+ min) | 27 | $3,150 | $95 |
| Return visit (30+ min) | 34 | $2,737 | $67 |
| Long return visit (40+ min) | 22 | $2,460 | $102 |
| New patient visit (45+ min) | 14 | $1,298 | $93 |
| Test to determine lung volumes using sensors | 82 | $975 | $11 |
| Test to examine how well the lungs exchange gases | 111 | $973 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 73 | $906 | $12 |
| Test to measure expiratory airflow and volume | 50 | $396 | $7 |
| Test to examine how well the lungs exchange gases | 43 | $364 | $8 |
| Test to measure expiratory airflow and volume | 41 | $321 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 18 | $219 | $12 |
| Test to determine lung volumes using sensors | 13 | $149 | $11 |
2019: 11 services
| Critical care, first 30-74 minutes | 30 | $10,054 | $193 |
| New patient visit (60+ min) | 18 | $2,714 | $151 |
| Long return visit (40+ min) | 15 | $2,166 | $98 |
| Long return visit (40+ min) | 15 | $1,592 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,290 | $92 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 66 | $795 | $12 |
| Test to determine lung volumes using sensors | 61 | $694 | $11 |
| Test to examine how well the lungs exchange gases | 74 | $626 | $8 |
| Test to examine how well the lungs exchange gases | 18 | $148 | $8 |
| Test to measure expiratory airflow and volume | 16 | $122 | $8 |
| Test to measure expiratory airflow and volume | 14 | $105 | $8 |
Medicaid work
$635 in 2024
Medicaid paid $635 for 82 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EVALUATION OF WHEEZING | 18 | $215 |
| Diffusing capacity | 37 | $213 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 14 | $118 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 13 | $90 |
| 2024 | 82 | 4 | 25 | $635 |
| 2023 | 82 | 3 | 21 | $643 |
| 2022 | 13 | 1 | 13 | $70 |
| 2021 | 15 | 1 | 15 | $69 |
| 2020 | 12 | 1 | 12 | $70 |
See the largest Medicaid services in earlier years
2023
| EVALUATION OF WHEEZING | 16 | $252 |
| Diffusing capacity | 51 | $252 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 15 | $139 |
2022
| Diffusing capacity | 13 | $70 |
2021
| Diffusing capacity | 15 | $69 |
2020
| Diffusing capacity | 12 | $70 |
Drugs they prescribed that Part D paid
$274,633
Pharmacies billed $274,633 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 696) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
344 generic and 352 brand-name prescriptions · $274,633 in drug cost · 154 antibiotic prescriptions to 59 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 67 | $51,542 | $769 |
| Spiriva Respimat | 38 | $22,087 | $581 |
| Anoro Ellipta | 33 | $17,882 | $542 |
| Breo Ellipta | 28 | $12,910 | $461 |
| Advair Diskus | 17 | $8,026 | $472 |
See all 19 drugs
| Trelegy Ellipta | 67 | $51,542 | $769 |
| Spiriva Respimat | 38 | $22,087 | $581 |
| Anoro Ellipta | 33 | $17,882 | $542 |
| Breo Ellipta | 28 | $12,910 | $461 |
| Advair Diskus | 17 | $8,026 | $472 |
| Incruse Ellipta | 16 | $7,367 | $460 |
| Advair Hfa | 19 | $6,776 | $357 |
| Symbicort | 24 | $5,138 | $214 |
| Albuterol Sulfate Hfa | 74 | $2,407 | $33 |
| Fluticasone-Salmeterol | 15 | $1,768 | $118 |
| Wixela Inhub | 22 | $1,676 | $76 |
| Azithromycin | 81 | $1,634 | $20 |
| Ethambutol | 28 | $1,486 | $53 |
| Rifampin | 35 | $1,440 | $41 |
| Cefpodoxime Proxetil | 20 | $1,293 | $65 |
| Doxycycline Hyclate | 23 | $980 | $43 |
| Ventolin Hfa | 11 | $573 | $52 |
| Montelukast | 16 | $154 | $10 |
| Prednisone | 25 | $63 | $3 |
Year by year
| 2024 | 696 | 127 | 0% (0) | 51% | $274,633 |
| 2023 | 774 | 113 | 0% (0) | 56% | $341,938 |
| 2022 | 545 | 118 | 0% (0) | 57% | $223,666 |
| 2021 | 813 | 119 | 0% (0) | 55% | $249,419 |
| 2020 | 552 | 95 | 0% (0) | 58% | $143,179 |
| 2019 | 104 | 44 | 0% (0) | 54% | $19,970 |
| 2017 | 19 | None | 0% (0) | 0% | $366 |
| 2016 | 157 | 30 | 0% (0) | None | $9,040 |
| 2015 | 347 | 55 | None | None | $28,451 |
| 2014 | 248 | 48 | None | None | $16,015 |
| 2013 | 83 | 28 | None | None | $1,868 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Trelegy Ellipta | 99 | $73,195 | $739 |
| Advair Diskus | 59 | $34,535 | $585 |
| Spiriva Handihaler | 27 | $26,094 | $966 |
| Anoro Ellipta | 32 | $23,123 | $723 |
| Symbicort | 46 | $22,593 | $491 |
| Breo Ellipta | 27 | $16,016 | $593 |
| Spiriva Respimat | 23 | $13,538 | $589 |
| Incruse Ellipta | 21 | $11,387 | $542 |
| Advair Hfa | 18 | $8,241 | $458 |
| Azithromycin | 90 | $3,411 | $38 |
| Albuterol Sulfate Hfa | 62 | $3,327 | $54 |
| Ethambutol | 20 | $1,418 | $71 |
| Ventolin Hfa | 12 | $1,340 | $112 |
| Cefpodoxime Proxetil | 12 | $1,118 | $93 |
| Rifampin | 18 | $1,113 | $62 |
| Montelukast | 43 | $868 | $20 |
| Ipratropium | 13 | $431 | $33 |
| Doxycycline Hyclate | 17 | $376 | $22 |
| Prednisone | 45 | $140 | $3 |
2022: 15 drugs
| Trelegy Ellipta | 59 | $48,602 | $824 |
| Anoro Ellipta | 37 | $25,028 | $676 |
| Advair Diskus | 23 | $23,184 | $1,008 |
| Spiriva Handihaler | 22 | $20,979 | $954 |
| Breo Ellipta | 35 | $16,777 | $479 |
| Symbicort | 29 | $12,603 | $435 |
| Incruse Ellipta | 32 | $12,529 | $392 |
| Spiriva Respimat | 18 | $9,755 | $542 |
| Advair Hfa | 13 | $5,304 | $408 |
| Azithromycin | 49 | $1,683 | $34 |
| Albuterol Sulfate Hfa | 33 | $1,502 | $46 |
| Ventolin Hfa | 12 | $933 | $78 |
| Montelukast | 38 | $891 | $23 |
| Ipratropium | 13 | $813 | $63 |
| Prednisone | 32 | $159 | $5 |
2021: 18 drugs
| Trelegy Ellipta | 67 | $42,376 | $632 |
| Anoro Ellipta | 70 | $37,082 | $530 |
| Advair Diskus | 42 | $34,298 | $817 |
| Breo Ellipta | 49 | $20,929 | $427 |
| Spiriva | 21 | $20,211 | $962 |
| Incruse Ellipta | 54 | $19,945 | $369 |
| Spiriva Respimat | 22 | $15,060 | $685 |
| Symbicort | 23 | $12,320 | $536 |
| Wixela Inhub | 20 | $10,397 | $520 |
| Advair Hfa | 12 | $5,942 | $495 |
| Albuterol Sulfate Hfa | 70 | $3,585 | $51 |
| Azithromycin | 77 | $3,023 | $39 |
| Budesonide-Formoterol | 11 | $2,926 | $266 |
| Rifampin | 22 | $2,280 | $104 |
| Ethambutol | 22 | $2,246 | $102 |
| Montelukast | 42 | $1,050 | $25 |
| Pantoprazole | 12 | $213 | $18 |
| Prednisone | 43 | $193 | $4 |
2020: 18 drugs
| Spiriva | 41 | $24,232 | $591 |
| Incruse Ellipta | 41 | $16,889 | $412 |
| Anoro Ellipta | 36 | $16,480 | $458 |
| Advair Diskus | 17 | $13,220 | $778 |
| Symbicort | 28 | $12,534 | $448 |
| Spiriva Respimat | 17 | $10,651 | $627 |
| Trelegy Ellipta | 11 | $8,518 | $774 |
| Budesonide-Formoterol | 24 | $7,793 | $325 |
| Breo Ellipta | 18 | $7,347 | $408 |
| Epinephrine | 11 | $2,799 | $254 |
| Albuterol Sulfate Hfa | 40 | $2,270 | $57 |
| Azithromycin | 43 | $1,551 | $36 |
| Ventolin Hfa | 17 | $972 | $57 |
| Montelukast | 30 | $626 | $21 |
| Fluticasone Propionate | 16 | $449 | $28 |
| Prednisone | 39 | $412 | $11 |
| Omeprazole | 16 | $369 | $23 |
| Pantoprazole | 13 | $158 | $12 |
2019: 1 drug
| Incruse Ellipta | 11 | $3,602 | $327 |
2016: 2 drugs
| Lisinopril | 19 | $87 | $5 |
| Alendronate | 11 | $24 | $2 |
2015: 7 drugs
| Lantus | 17 | $5,922 | $348 |
| Gabapentin | 14 | $534 | $38 |
| Levothyroxine | 13 | $236 | $18 |
| Lisinopril | 44 | $224 | $5 |
| Simvastatin | 21 | $135 | $6 |
| Amlodipine Besylate | 18 | $107 | $6 |
| Hydrochlorothiazide | 11 | $44 | $4 |
2014: 4 drugs
| Metformin | 13 | $153 | $12 |
| Lisinopril | 21 | $134 | $6 |
| Pantoprazole | 12 | $130 | $11 |
| Amlodipine Besylate | 12 | $86 | $7 |
Money from drug and device companies
$113 in 2025
| 2025 | 1 | 1 | None | $113 |
| 2024 | 1 | 7 | $5,040 | $6,996 |
| 2019 | 2 | 2 | None | $129 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Baxter Healthcare | Hillrom - Monarch Airway Clearance System | $113 | 1 payment
|
See the published payment
| Baxter Healthcare | Meals · 2025-05-22 | Hillrom - Monarch Airway Clearance System | $113 |
See earlier years (2024, 2019)
2024: $6,996
| Insmed | Arikayce | $6,996 | 7 payments
|
2019: $129
| Genentech USA | Esbriet | $100 | 1 payment
|
| Insmed | Arikayce | $29 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Insmed, Inc. · Arikayce · 2023 | This clinician | $1,432 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1003253147
- Licence
- CA A141347, RI LP02822California A141347: Current · expires 2027-11-30
- Trained
- University of Arizona College of Medicine, 2013
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2013-05-30
- NPI last updated
- 2024-04-15
- NPI record certified
- 2024-04-15
This is when the NPI record was last certified, not a medical board exam.